Concarlo Therapeutics is developing a drug that could transform the way we treat cancer. In this episode, Co-founder, Chief Scientific Officer, and acting CEO of Concarlo Therapeutics, Dr. Stacy Blain,shares her journey of researching, testing and securing funding for a drug that kills off cancer cells.
Join us as we discuss:
- Clinical grade manufacturing processes
- FDA regulations and clinical trials
- Cancer cell proliferation and necrosis